Back to Agenda
Session 3 Tract 2 - Communications: Social Media
Session Chair(s)
Deirdre Cozier
Director, Global Regulatory Affairs
Pharmascience, Canada
The increasing popularity of social media networks is changing consumer behavior. An entire generation now communicates via tweets, pins and IMs. Consumer endorsement has a powerful, and near instantaneous, effect on company strategy. This has required the business community to adapt to this technology and engage their customers in more personal and virtual ways. In an industry as tightly regulated as pharmaceuticals, the use of social media platforms to engage, inform and promote raises some unique challenges. This session will explore the uses of social media both from an industry and regulator perspective. From R&D, to internal collaboration and compliance considerations, the three speakers will share best practices and provide valuable tips to ensure that your use of social media platforms is successful.
Speaker(s)
Harnessing Power of SMAC (Social Media, Mobility, Analytics & Cloud) to Drive Transformation in Clinical R&D
Susant Mallick, MBA
Cloudhub BV, Netherlands
Founder and CEO, Life Sciences Practice Leader
Social Media as Health Communication Tools in Canada
Brenda M Gryfe, MPharm
OptumInsight (Canada) Inc., Canada
Director, Canadian Regulatory Affairs
Regulatory Considerations of Using Social Media
Alain G. Musende, PhD
Marketed Health Products Directorate, Health Canada, Canada
Manager, Section for Transparency and Advertising Regulatory Surveillance
Have an account?